KN HOSPITAL (02120) Income Statement & Earnings

9.050
0.0000.00%

Market Closed May 15 11:20 CST

654.85MMarket Cap10.88P/E (TTM)

KN HOSPITAL (02120) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-2.09%1.62B

-10.90%738.56M

3.63%1.65B

6.56%828.96M

7.50%1.6B

5.37%777.93M

14.45%1.48B

21.48%738.3M

31.18%1.3B

30.65%607.74M

Operating income

-2.09%1.62B

-10.90%738.56M

3.63%1.65B

6.56%828.96M

7.50%1.6B

5.37%777.93M

14.45%1.48B

21.48%738.3M

31.18%1.3B

30.65%607.74M

Operating expenses

1.25%-1.2B

8.87%-549.33M

-2.60%-1.22B

-4.58%-602.8M

-4.70%-1.19B

-6.63%-576.39M

-16.89%-1.13B

-19.02%-540.54M

-32.81%-968.43M

-34.81%-454.14M

Gross profit

-4.41%419.07M

-16.33%189.23M

6.63%438.4M

12.22%226.16M

16.49%411.14M

1.90%201.53M

7.27%352.93M

28.76%197.77M

26.62%329M

19.73%153.6M

Selling expenses

22.46%-7.73M

60.12%-3.69M

41.69%-9.97M

-18.15%-9.25M

-13.99%-17.1M

-28.00%-7.83M

-45.17%-15M

-24.85%-6.12M

-28.03%-10.34M

-32.50%-4.9M

Administrative expenses

-2.53%-233.11M

-14.63%-121.82M

-6.72%-227.35M

-4.27%-106.27M

-3.47%-213.03M

-7.41%-101.92M

-16.73%-205.89M

-24.76%-94.89M

-37.39%-176.37M

-39.21%-76.06M

Research and development expenses

17.51%-30.12M

10.95%-15.66M

-12.49%-36.52M

-17.58%-17.59M

1.70%-32.47M

0.69%-14.96M

-18.12%-33.03M

-27.58%-15.06M

-33.33%-27.96M

-347.63%-11.81M

Profit from asset sales

3,509.06%2.38M

1,767.19%1.25M

-202.71%-69.93K

---74.99K

-83.24%68.09K

----

611.55%406.18K

--389.32K

-113.31%-79.4K

----

Revaluation surplus

-1,020.25%-3.02M

585.01%477.84K

-225.81%-269.74K

---98.52K

101.34%214.41K

----

-269.66%-15.98M

-97.73%30.71K

42.70%9.42M

--1.35M

-Changes in the fair value of other assets

-1,020.25%-3.02M

585.01%477.84K

-225.81%-269.74K

---98.52K

101.34%214.41K

----

-269.66%-15.98M

-97.73%30.71K

42.70%9.42M

--1.35M

Impairment and provision

25.40%-32.04M

236.40%7.62M

-359.14%-42.95M

-85.53%-5.58M

73.68%-9.35M

-10.19%-3.01M

-327.15%-35.54M

-18.09%-2.73M

2.07%-8.32M

85.64%-2.31M

-Other impairment is provision

25.40%-32.04M

236.40%7.62M

-359.14%-42.95M

-85.53%-5.58M

73.68%-9.35M

-10.19%-3.01M

-327.15%-35.54M

-18.09%-2.73M

2.07%-8.32M

85.64%-2.31M

Special items of operating profit

92.07%26.91M

112.34%15.43M

41.37%14.01M

29.18%7.27M

-44.20%9.91M

0.02%5.63M

-13.62%17.76M

-47.55%5.63M

795.26%20.56M

137.32%10.73M

Operating profit

6.62%131.09M

-23.30%67.72M

-13.97%122.95M

15.18%88.29M

135.42%142.9M

-7.64%76.66M

-53.36%60.7M

21.43%83M

32.81%130.15M

27.24%68.35M

Financing income

-73.02%842.39K

-78.13%587.38K

-40.69%3.12M

-0.69%2.69M

90.66%5.27M

259.19%2.7M

63.29%2.76M

-0.87%-1.7M

-63.84%1.69M

31.37%-1.68M

Financing cost

6.11%-39.06M

21.21%-18.38M

-4.17%-41.6M

-21.59%-23.32M

11.55%-39.94M

15.87%-19.18M

-24.49%-45.15M

-24.24%-22.8M

-35.26%-36.27M

-30.28%-18.35M

Special items of earning before tax

-115.25%-15.61M

-61.37%-3.73M

-219.56%-7.25M

-162.34%-2.31M

-188.42%-2.27M

87.44%3.71M

-124.60%-787.06K

-24.72%1.98M

628.67%3.2M

206.43%2.63M

Earning before tax

1.64%69.22M

-31.75%41.98M

-31.34%68.1M

2.17%61.51M

535.58%99.18M

-4.93%60.21M

-83.69%15.6M

17.84%63.33M

28.76%95.69M

36.39%53.74M

After-tax profit from continuing operations

-27.37%36.6M

-40.51%26.77M

-42.03%50.4M

-7.66%45M

892.53%86.93M

10.20%48.73M

-126.84%-10.97M

22.03%44.22M

-6.40%40.86M

25.39%36.24M

Earning after tax

-27.37%36.6M

-40.51%26.77M

-42.03%50.4M

-7.66%45M

892.53%86.93M

10.20%48.73M

-126.84%-10.97M

22.03%44.22M

-6.40%40.86M

25.39%36.24M

Minority profit

-16.96%-17.79M

-70.43%-9.76M

-1,646.30%-15.21M

-215.03%-5.73M

-92.58%983.8K

-8.35%4.98M

517.28%13.25M

339.93%5.43M

73.78%-3.18M

116.45%1.23M

Profit attributable to shareholders

-17.09%54.4M

-27.98%36.53M

-23.66%65.61M

15.94%50.72M

454.85%85.95M

12.79%43.75M

-155.00%-24.22M

10.81%38.79M

-21.04%44.04M

-3.86%35M

Basic earnings per share

-13.64%0.76

-26.47%0.5

-23.48%0.88

15.25%0.68

459.38%1.15

13.46%0.59

-152.46%-0.32

8.33%0.52

-20.78%0.61

-4.00%0.48

Diluted earnings per share

-13.64%0.76

-26.47%0.5

-23.48%0.88

15.25%0.68

459.38%1.15

13.46%0.59

-154.24%-0.32

8.33%0.52

-21.33%0.59

-4.00%0.48

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-2.09%1.62B	-10.90%738.56M	3.63%1.65B	6.56%828.96M	7.50%1.6B	5.37%777.93M	14.45%1.48B	21.48%738.3M	31.18%1.3B	30.65%607.74M
Operating income	-2.09%1.62B	-10.90%738.56M	3.63%1.65B	6.56%828.96M	7.50%1.6B	5.37%777.93M	14.45%1.48B	21.48%738.3M	31.18%1.3B	30.65%607.74M
Operating expenses	1.25%-1.2B	8.87%-549.33M	-2.60%-1.22B	-4.58%-602.8M	-4.70%-1.19B	-6.63%-576.39M	-16.89%-1.13B	-19.02%-540.54M	-32.81%-968.43M	-34.81%-454.14M
Gross profit	-4.41%419.07M	-16.33%189.23M	6.63%438.4M	12.22%226.16M	16.49%411.14M	1.90%201.53M	7.27%352.93M	28.76%197.77M	26.62%329M	19.73%153.6M
Selling expenses	22.46%-7.73M	60.12%-3.69M	41.69%-9.97M	-18.15%-9.25M	-13.99%-17.1M	-28.00%-7.83M	-45.17%-15M	-24.85%-6.12M	-28.03%-10.34M	-32.50%-4.9M
Administrative expenses	-2.53%-233.11M	-14.63%-121.82M	-6.72%-227.35M	-4.27%-106.27M	-3.47%-213.03M	-7.41%-101.92M	-16.73%-205.89M	-24.76%-94.89M	-37.39%-176.37M	-39.21%-76.06M
Research and development expenses	17.51%-30.12M	10.95%-15.66M	-12.49%-36.52M	-17.58%-17.59M	1.70%-32.47M	0.69%-14.96M	-18.12%-33.03M	-27.58%-15.06M	-33.33%-27.96M	-347.63%-11.81M
Profit from asset sales	3,509.06%2.38M	1,767.19%1.25M	-202.71%-69.93K	---74.99K	-83.24%68.09K	----	611.55%406.18K	--389.32K	-113.31%-79.4K	----
Revaluation surplus	-1,020.25%-3.02M	585.01%477.84K	-225.81%-269.74K	---98.52K	101.34%214.41K	----	-269.66%-15.98M	-97.73%30.71K	42.70%9.42M	--1.35M
-Changes in the fair value of other assets	-1,020.25%-3.02M	585.01%477.84K	-225.81%-269.74K	---98.52K	101.34%214.41K	----	-269.66%-15.98M	-97.73%30.71K	42.70%9.42M	--1.35M
Impairment and provision	25.40%-32.04M	236.40%7.62M	-359.14%-42.95M	-85.53%-5.58M	73.68%-9.35M	-10.19%-3.01M	-327.15%-35.54M	-18.09%-2.73M	2.07%-8.32M	85.64%-2.31M
-Other impairment is provision	25.40%-32.04M	236.40%7.62M	-359.14%-42.95M	-85.53%-5.58M	73.68%-9.35M	-10.19%-3.01M	-327.15%-35.54M	-18.09%-2.73M	2.07%-8.32M	85.64%-2.31M
Special items of operating profit	92.07%26.91M	112.34%15.43M	41.37%14.01M	29.18%7.27M	-44.20%9.91M	0.02%5.63M	-13.62%17.76M	-47.55%5.63M	795.26%20.56M	137.32%10.73M
Operating profit	6.62%131.09M	-23.30%67.72M	-13.97%122.95M	15.18%88.29M	135.42%142.9M	-7.64%76.66M	-53.36%60.7M	21.43%83M	32.81%130.15M	27.24%68.35M
Financing income	-73.02%842.39K	-78.13%587.38K	-40.69%3.12M	-0.69%2.69M	90.66%5.27M	259.19%2.7M	63.29%2.76M	-0.87%-1.7M	-63.84%1.69M	31.37%-1.68M
Financing cost	6.11%-39.06M	21.21%-18.38M	-4.17%-41.6M	-21.59%-23.32M	11.55%-39.94M	15.87%-19.18M	-24.49%-45.15M	-24.24%-22.8M	-35.26%-36.27M	-30.28%-18.35M
Special items of earning before tax	-115.25%-15.61M	-61.37%-3.73M	-219.56%-7.25M	-162.34%-2.31M	-188.42%-2.27M	87.44%3.71M	-124.60%-787.06K	-24.72%1.98M	628.67%3.2M	206.43%2.63M
Earning before tax	1.64%69.22M	-31.75%41.98M	-31.34%68.1M	2.17%61.51M	535.58%99.18M	-4.93%60.21M	-83.69%15.6M	17.84%63.33M	28.76%95.69M	36.39%53.74M
After-tax profit from continuing operations	-27.37%36.6M	-40.51%26.77M	-42.03%50.4M	-7.66%45M	892.53%86.93M	10.20%48.73M	-126.84%-10.97M	22.03%44.22M	-6.40%40.86M	25.39%36.24M
Earning after tax	-27.37%36.6M	-40.51%26.77M	-42.03%50.4M	-7.66%45M	892.53%86.93M	10.20%48.73M	-126.84%-10.97M	22.03%44.22M	-6.40%40.86M	25.39%36.24M
Minority profit	-16.96%-17.79M	-70.43%-9.76M	-1,646.30%-15.21M	-215.03%-5.73M	-92.58%983.8K	-8.35%4.98M	517.28%13.25M	339.93%5.43M	73.78%-3.18M	116.45%1.23M
Profit attributable to shareholders	-17.09%54.4M	-27.98%36.53M	-23.66%65.61M	15.94%50.72M	454.85%85.95M	12.79%43.75M	-155.00%-24.22M	10.81%38.79M	-21.04%44.04M	-3.86%35M
Basic earnings per share	-13.64%0.76	-26.47%0.5	-23.48%0.88	15.25%0.68	459.38%1.15	13.46%0.59	-152.46%-0.32	8.33%0.52	-20.78%0.61	-4.00%0.48
Diluted earnings per share	-13.64%0.76	-26.47%0.5	-23.48%0.88	15.25%0.68	459.38%1.15	13.46%0.59	-154.24%-0.32	8.33%0.52	-21.33%0.59	-4.00%0.48
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--
Auditor	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--	Lixin Certified Public Accountants (Special General Partnership)	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"